Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by ANALIAS00on Dec 06, 2021 8:42am
81 Views
Post# 34201464

RE:RE:RE:RE:RE:RE:Options

RE:RE:RE:RE:RE:RE:Options That would be considered as 'deli d'initi' in my opinion



palinc2000]So it appears that they have NOT been trying to prop up the share price  to get a lower exercise price on the options .....sickening sickening sickening !!!! Hard to accept quotethat Paul would be playing such game ,,,,I hope I am reading this wrong


SABBOBCAT wrote: I commented a while back (or meant to) about how they were dragging this out so they could keep the price low and grant a bunch of options... I was talking March, not December. I am excited because it signals something material must be coming shortly, but I am appalled by the blatant exploitation of shareholders.

They know shareholders were pissed after the OO and are now frustrated by the lack of communication and low share price, so that do they do? "Hey let's grant ourselves a ton of options 3 days into the new fiscal year (3-4 months earlier than normal) to pad our already generous options comp before finally releasing positive news”. This makes me sick as a shareholder that has seen nothing by disregard from management and IR over the last few years. It looks super GREASY and management should be ashamed.



[/quote]
<< Previous
Bullboard Posts
Next >>